# Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

> **NCT05924945** · NA · TERMINATED · sponsor: **Masimo Corporation** · enrollment: 13 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DEVICE:** Bridge™ active device
- **DEVICE:** Bridge™ sham device

## Key facts

- **NCT ID:** NCT05924945
- **Lead sponsor:** Masimo Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-06-08
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-08-19
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2025-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05924945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05924945, "Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05924945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*